Pepper Bio
United States · $6.5M raised
- Business Model
- B2B
- Total Funding
- $6.5M
- Last Round
- $6.5M SeedNov 2023
- Rounds
- 1
About
Accelerates drug discovery for untreatable diseases
Summary
Pepper Bio is a Biotech company based in United States. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Nov 2023. Investors include NFX.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2023
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...